Impact of smoking status on EGFR-TKI efficacy for advanced non-small-cell lung cancer in EGFR mutants: A meta-analysis

Clinical Lung Cancer

Volumn 16, Issue 2, 2015, Pages 144-151.e1

  Zhang, Yaxiong ^a,b,c   Kang, Shiyang ^a,b,c   Fang, Wenfeng ^a,b   Hong, Shaodong ^a,b   Liang, Wenhua ^a,b   Yan, Yue ^a,b   Qin, Tao ^a,b   Tang, Yanna ^a,b   Sheng, Jin ^a,b   Zhang, Li ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b Department of Colorectal Surgery   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

EGFR mutation; Meta analysis; Non small cell lung cancer; Smoking; TKI

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN KINASE INHIBITOR;

ADVERSE EFFECTS; ANTAGONISTS AND INHIBITORS; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE FREE SURVIVAL; EPIDEMIOLOGY; GENETICS; HUMAN; LUNG NEOPLASMS; META ANALYSIS; MUTATION; PATHOLOGY; SMOKING; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; HUMANS; LUNG NEOPLASMS; MUTATION; PROTEIN KINASE INHIBITORS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SMOKING; TREATMENT OUTCOME;

EID: 84923006645     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2014.09.008     Document Type: Article

References (32)

1. E.L. Wynder, and E.A. Graham Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma: a study of six hundred and eighty-four proved cases JAMA 253 1985 2986 2994
2. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108
3. S. Sun, J.H. Schiller, and A.F. Gazdar Lung cancer in never smokers - a different disease Nat Rev Cancer 7 2007 778 790
4. C. Toh, E. Wong, and W. Lim The impact of smoking status on the behavior and survival outcome of patients with advanced non-small cell lung cancer: a retrospective analysis Chest 126 2004 1750 1756
5. G. Grsel, E. Levent, and C. Oztrk Hospital based survey of lung cancer in Turkey, a developing country, where smoking is highly prevalent Lung Cancer 21 1998 127 132
6. C. Lee, K.H. Kang, and Y. Koh Characteristics of lung cancer in Korea, 1997 Lung Cancer 30 2000 15 22
7. R.T. Heelan, V. Rusch, and M. Zakowski Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer J Clin Oncol 22 2004 1103 1109
8. F.A. Shepherd, J.R. Pereira, and T. Ciuleanu Erlotinib in previously treated non-small-cell lung cancer N Engl J Med 353 2005 123 132
9. R.S. Herbst, D. Prager, and R. Hermann TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer J Clin Oncol 23 2005 5892 5899
10. H. Shigematsu, L. Lin, and T. Takahashi Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers J Natl Cancer Inst 97 2005 339 346
11. M. Ahn, B. Park, and J.S. Ahn Are there any ethnic differences in molecular predictors of erlotinib efficacy in advanced non-small cell lung cancer? Clin Cancer Res 14 2008 3860 3866
12. Y. Tomizawa, H. Iijima, and N. Sunaga Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer Clin Cancer Res 11 2005 6816 6822
13. R. Hsieh, K. Lim, and H. Kuo Female sex and bronchioloalveolar pathologic subtype predict EGFR mutations in non-small cell lung cancer Chest 128 2005 317 321
14. M. Tokumo, S. Toyooka, and K. Kiura The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers Clin Cancer Res 11 2005 1167 1173
15. D. Pham, M.G. Kris, and G.J. Riely Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas J Clin Oncol 24 2006 1700 1704
16. P. Mitchell, T. Mok, and H. Barraclough Smoking history as a predictive factor of treatment response in advanced non-small-cell lung cancer: a systematic review Clin Lung Cancer 13 2012 239 251
17. M.H. Kim, H.R. Kim, and B.C. Cho Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations Lung Cancer 84 2014 196 202
18. M. Egger, G.D. Smith, and M. Schneider Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
19. C.B. Begg, and M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
20. T.Y. Chou, C.H. Chiu, and L.H. Li Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer Clin Cancer Res 2005 3750 3757
21. H. Asahina, K. Yamazaki, and I. Kinoshita A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations Br J Cancer 2006 998 1004
22. R. Rosell, T. Moran, and C. Queralt Screening for epidermal growth factor receptor mutations in lung cancer N Engl J Med 2009 958 967
23. J.M. Xu, Y. Han, and H.Q. Duan EGFR mutations and HER2/3 protein expression and clinical outcome in Chinese advanced non-small cell lung cancer patients treated with gefitinib J Cancer Res Clin Oncol 2009 771 782
24. Y.W. Won, J.Y. Han, and G.K. Lee Comparison of clinical outcome of patients with non-small-cell lung cancer harbouring epidermal growth factor receptor exon 19 or exon 21 mutations J Clin Pathol 2011 947 952
25. C.M. Choi, M.Y. Kim, and J.C. Lee Advanced lung adenocarcinoma harboring a mutation of the epidermal growth factor receptor: CT findings after tyrosine kinase inhibitor therapy Radiology 2014 574 582
26. J. Fukihara, N. Watanabe, and H. Taniguchi Clinical predictors of response to EGFR tyrosine kinase inhibitors in patients with EGFR-mutant non-small cell lung cancer Oncology 2014 86 93
27. S.H. Lim, J.Y. Lee, and J.M. Sun Comparison of clinical outcomes following gefitinib and erlotinib treatment in non-small-cell lung cancer patients harboring an epidermal growth factor receptor mutation in either exon 19 or 21 J Thorac Oncol 9 2014 506 511
28. S.S. Hecht Lung carcinogenesis by tobacco smoke Int J Cancer 131 2012 2724 2732
29. L. Ding, G. Getz, and D.A. Wheeler Somatic mutations affect key pathways in lung adenocarcinoma Nature 455 2008 1069 1075
30. W. Lee, Z. Jiang, and J. Liu The mutation spectrum revealed by paired genome sequences from a lung cancer patient Nature 465 2010 473 477
31. S. Filosto, C.R. Becker, and T. Goldkorn Cigarette smoke induces aberrant EGF receptor activation that mediates lung cancer development and resistance to tyrosine kinase inhibitors Mol Cancer Ther 11 2012 795 804
32. S. Filosto, D.S. Baston, and S. Chung Src mediates cigarette smoke-induced resistance to tyrosine kinase inhibitors in NSCLC cells Mol Cancer Ther 12 2013 1579 1590